Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis

Journal:

PLOS Medicine

Published:

2025-08-26

DOI:

10.1371/journal.pmed.1004663

Affiliations:

9

Authors:

15

Go to article

Institutions	Authors	Share
Hull York Medical School (HYMS), United Kingdom (UK)	5.500000	0.37
Cardiff University, United Kingdom (UK)	3.000000	0.20
Leiden University Medical Center (LUMC), Netherlands	2.000000	0.13
University of Hull, United Kingdom (UK)	2.000000	0.13
Erasmus MC Cancer Institute, Netherlands	1.000000	0.07
Aalborg University Hospital, Denmark	1.000000	0.07
Centre for Advancement in Realist Evaluation and Synthesis (CARES), Canada	0.500000	0.03

Interested in Health Services and Systems?